It facilitated us to perform a targeted multi-omics approach that enabled us to investigate the relationship between PON1 status and obesity-associated liver pathology as well as to explore the potential involvement of PON1 (epi)genetics in the regulation of its gene expression and catalytic efficiency. The gene discussed is PON1; the disease is obesity disorder.